Sutro Biopharma, Inc. (STRO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Sutro Biopharma, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.51x | -0.62x | -2.42x | -3.44x | -6.50x | -22.01x |
| P/B Ratio | -0.74x | 3.17x | 1.72x | 1.89x | 2.72x | 2.13x |
| P/S Ratio | 0.96x | 2.28x | 1.68x | 6.05x | 11.09x | 16.55x |
| Profitability | ||||||
| Gross Margin | 92.9% | 88.4% | 95.6% | 87.8% | 84.2% | -80.1% |
| Operating Margin | -102.4% | -384.3% | -58.1% | -190.3% | -159.2% | -166.3% |
| Net Margin | -186.5% | -366.6% | -69.5% | -175.9% | -170.6% | -75.2% |
| EBITDA Margin | -95.3% | -290.9% | -44.2% | -155.0% | -157.7% | -55.6% |
| Liquidity | ||||||
| Current Ratio | 2.01x | 2.60x | 4.50x | 5.31x | 5.24x | 12.78x |
| Quick Ratio | 2.01x | 2.60x | 4.50x | 5.31x | 5.24x | 12.78x |
| Leverage | ||||||
| Debt/Equity | -0.12x | 0.52x | 0.22x | 0.25x | 0.23x | 0.07x |
YoY = year-over-year change. Source: FMP..